PONTE VEDRA, Fla., Dec. 11, 2025 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition...

Biotech Showcase 2023
Event | 01. 10. 2023
Elizabeth Kelly will be participating on a panel titled "Finance Trends in Asia Pacific" on Tuesday, January 10th at the Biotech Showcase 2023 in San Francisco.
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.